Two More Patents Issued
East Lansing, Michigan (November 14, 2012): Retia Medical, LLC, announced today that two of its patent applications have issued. These patents, US 8,282,569 and US 8,273,031, expand Retia’s broad coverage in the area of cardiovascular signal processing to enable accurate monitoring of critically ill patients using less invasive sensors.
Recent Press Releases:
- Retia Medical Announces the acquisition of its Argos hemodynamic monitor by Temple University
- Retia Medical awarded a Hemodynamic Monitoring Products agreement with Premier, Inc.
- Retia Medical and The JANZ Corporation Announce Strategic Partnership Agreement
- Retia Medical presenting at STS, SCCM, and Arab Health!